Aliases & Classifications for Pityriasis Rosea

About this section

Aliases & Descriptions for Pityriasis Rosea:

Name: Pityriasis Rosea 10 12 36 65
 
Pityriasis Circinata 10

Classifications:



External Ids:

Disease Ontology10 DOID:8892
ICD1027 L42
ICD9CM29 696.3
SNOMED-CT59 156373006, 77252004
MeSH36 D017515
NCIt42 C26855
UMLS65 C0032026

Summaries for Pityriasis Rosea

About this section
Wikipedia:68 Pityriasis rosea (also known as pityriasis rosea Gibert) is a skin rash. It is benign but may inflict... more...

MalaCards based summary: Pityriasis Rosea, also known as pityriasis circinata, is related to retinitis and cryptosporidiosis. An important gene associated with Pityriasis Rosea is HLA-C (Major Histocompatibility Complex, Class I, C), and among its related pathways are Immune response IFN alpha/beta signaling pathway and Antigen Presentation- Folding, assembly and peptide loading of class I MHC. The drugs methdilazine and methdilazine hydrochloride have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and endothelial.

Related Diseases for Pityriasis Rosea

About this section

Diseases related to Pityriasis Rosea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 357)
idRelated DiseaseScoreTop Affiliating Genes
1retinitis30.3HLA-A, HLA-B
2cryptosporidiosis29.9HLA-A, HLA-B, HLA-DRB1
3rheumatoid arthritis29.7HLA-B, HLA-DQB1, HLA-DRB1, HLA-DRB5
4artery disease29.5HLA-A, HLA-B, HLA-DQB1, HLA-DRB1
5pityriasis rotunda10.6
6leukemia10.5
7endotheliitis10.5
8breast cancer10.4
9lymphoma10.4
10esophagitis10.4
11neuronitis10.4
12adenocarcinoma10.4
13cardiomyopathy10.4
14cystic fibrosis10.3
15lymphoblastic leukemia10.3
16hypothyroidism10.3
17prostatitis10.3
18cerebritis10.3
19pancreatitis10.3
20hypoxia10.3
21lichen planus pemphigoides10.3HLA-DQB1, HLA-DRB1
22tucker syndrome10.3HLA-DQB1, HLA-DRB1
23heavy chain deposition disease10.3HLA-DQB1, HLA-DRB1
24pulmonary coin lesion10.2HLA-DQB1, HLA-DRB1
25hemorrhagic fever with renal syndrome10.2HLA-C, HLA-DRB1
26autoimmune polyglandular syndrome type 210.2HLA-DQB1, HLA-DRB1
27drug-induced mental disorder10.2HLA-C, HLA-DRB1
28best1 retinopathy10.2HLA-DQB1, HLA-DRB1
29non-distal monosomy 10q10.2HLA-DQB1, HLA-DRB1
30lichtenstein syndrome10.2HLA-DQB1, HLA-DRB1
31red cell phospholipid defect with hemolysis10.2HLA-DQB1, HLA-DRB1
32actinomycosis10.2HLA-DQB1, HLA-DRB1
33microsomia hemifacial radial defects10.2HLA-B, HLA-DRB1
34finnish upper limb-onset distal myopathy10.2HLA-DQB1, HLA-DRB1
35systemic lupus erythematosus10.2
36prostate cancer10.2
37hepatocellular carcinoma10.2
38asthma10.2
39obesity10.2
40leprosy10.2
41alzheimer disease10.2
42arthritis10.2
43cholangiocarcinoma10.2
44gastric cancer10.2
45hematopoietic stem cell transplantation10.2
46gallbladder disease10.2
47pre-eclampsia10.2
48sarcoma10.2
49eclampsia10.2
50cervicitis10.2

Graphical network of the top 20 diseases related to Pityriasis Rosea:



Diseases related to pityriasis rosea

Symptoms for Pityriasis Rosea

About this section

Drugs & Therapeutics for Pityriasis Rosea

About this section

Drugs for Pityriasis Rosea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Tacrolimusapproved, investigationalPhase 41023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
2
Calcitriolapproved, nutraceuticalPhase 416132222-06-3134070, 5280453
Synonyms:
(1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol
(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha,25-Dihydroxyvitamin D3
1,25 (OH)2 D3
1,25 Dihydroxycholecalciferol
1,25(OH)2-20epi-D3
1,25(OH)2D3 & CD4
1,25(OH2)D3
1,25-(OH)2-D3
1,25-(OH)2D3
1,25-DHCC
1,25-DIHYDROXYCHOLECALCIFEROL
1,25-Dihydroxycholecalciferol
1,25-Dihydroxycholecaliferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1,25-dihydroxy vitamin D3
1,25-dihydroxy-20-epi-Vitamin D3
1,25-dihydroxycholecalciferol
1,25D3
1-alpha,-1,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxycholecalciferol
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1-alpha-25-dihydroxyvitamin D3
1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3
17936_FLUKA
17936_SIGMA
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1alpha,25(OH)2-D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D
1alpha,25-Dihydroxyvitamin D3
1db1
1α,25(OH)2D3
1α,25-dihydroxycholecalciferol
1α,25-dihydroxyvitamin D3
20-epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
32222-06-3
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4
9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol
AC-1859
AC1NQX1S
 
Ambap32222-06-3
Asentar
BCBcMAP01_000160
BML2-E03
BSPBio_001287
C01673
CCRIS 5522
CD-2027
CHEBI:17823
CHEMBL846
CID5280453
CPD000466393
Calcijex
Calcijex, Silkis, Rocaltrol, Topitriol, Cholecalciferol,Calcitriol
Calcitriol
Calcitriol (JAN/USAN/INN)
Calcitriol [USAN:INN:BAN:JAN]
Calcitriolum
Calcitriolum [INN-Latin]
D00129
D1530_SIGMA
DN 101
DN-101
Decostriol
Dihydroxyvitamin D3
EINECS 250-963-8
HMS1361A09
HMS1791A09
HMS1989A09
HMS2051F06
HMS2089N03
HSDB 3482
IDI1_033757
LMST03020258
LS-53093
MC-1288
MC1288
MLS000759536
MLS001424122
MolPort-002-045-698
NCGC00161327-01
NCGC00161327-04
Ro 21-5535
Ro 215535
Ro-21-5535
Rocaltrol
Rocaltrol (TN)
S1466_Selleck
SAM001246772
SMR000466393
Silkis
Soltriol
Spectrum5_002061
Topitriol
Toptriol
U 49562
Vectical
ZINC03924790
calcitriol
vit D
3PetrolatumPhase 484
4Trace ElementsPhase 43900
5vitamin dPhase 41524
6VitaminsPhase 43857
7MicronutrientsPhase 43901
8Vasoconstrictor AgentsPhase 41303
9Immunosuppressive AgentsPhase 410422
10Calcium, DietaryPhase 44678
11Calcineurin InhibitorsPhase 41223
12Dermatologic AgentsPhase 44555
13EmollientsPhase 4121
14Immunologic FactorsPhase 418483
15Bone Density Conservation AgentsPhase 42600

Interventional clinical trials:

idNameStatusNCT IDPhase
1Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis AlbaCompletedNCT01388517Phase 4

Search NIH Clinical Center for Pityriasis Rosea

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: pityriasis rosea

Genetic Tests for Pityriasis Rosea

About this section

Anatomical Context for Pityriasis Rosea

About this section

MalaCards organs/tissues related to Pityriasis Rosea:

33
Skin, Breast, Endothelial, Brain, T cells, Bone, Testes

Animal Models for Pityriasis Rosea or affiliated genes

About this section

MGI Mouse Phenotypes related to Pityriasis Rosea:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Pityriasis Rosea

About this section

Articles related to Pityriasis Rosea:

(show top 50)    (show all 381)
idTitleAuthorsYear
1
Subclavian steal syndrome: a case report and review of advances in diagnostic and treatment approaches. (26698195)
2016
2
Sexual function in women undergoing surgery for deep infiltrating endometriosis: a comparison with healthy women. (25883096)
2015
3
CHA2DS2-VASc score is a useful-predictor of not prognosis but coronary-arteriosclerosis in chronic atrial-fibrillation compared with CHADS2 score: A two-center study of 320-slice CT, part 2. (25245494)
2014
4
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study. (25873782)
2014
5
Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease. (24680777)
2014
6
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). (23747002)
2013
7
Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma. (24326836)
2013
8
Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia. (23829279)
2013
9
Spectral domain optical coherence tomography findings in bilateral peripheral cone dystrophy. (23456543)
2013
10
Human RioK3 is a novel component of cytoplasmic pre-40S pre-ribosomal particles. (22418843)
2012
11
Oral paliperidone: a review of its use in the management of schizoaffective disorder. (21649452)
2011
12
Corrective lens use and refractive error among United States Air Force aircrew. (20358711)
2010
13
Effects of HBsAg pulsed dendritic vaccination on anti-HBs production in immunosuppressed rats after liver transplantation]. (20128966)
2010
14
Study of CD21-positive FDC-like structures in MALT lymphoma: Does it provide helpful information for histopathological diagnosis? (20712652)
2010
15
Increased cyclooxygenase-2 expression in juvenile polyposis syndrome. (19124115)
2009
16
The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. (19285439)
2009
17
Epoetin and nephrogenic systemic fibrosis. (18158932)
2008
18
Creatine kinase increase under simvastatin--therapeutic consequences?]. (18522017)
2008
19
The expression of molecular mediators in the idiopathic cutaneous calcification and ossification. (18422975)
2008
20
Acute anal stretch inhibits NMDA-dependent pelvic-urethra reflex potentiation via spinal GABAergic inhibition in anesthetized rats. (18632795)
2008
21
Relationship between hyperuricemia and metabolic syndrome]. (18409529)
2008
22
Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels. (17823919)
2007
23
Altered in vitro chondrogenic properties of chondrocytes harvested from unaffected cartilage in osteoarthritic joints. (16735197)
2006
24
Revision cochlear implantation for facial nerve stimulation in otosclerosis. (16618909)
2006
25
Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia. (16079929)
2005
26
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region. (15905070)
2005
27
Defining a holoprosencephaly locus on human chromosome 14q13 and characterization of potential candidate genes. (15820313)
2005
28
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. (15026322)
2004
29
The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. (15520413)
2004
30
Bilateral hip dislocation and pubic diastasis in familial nail-patella syndrome. (12650329)
2003
31
Otosclerosis and chronic tinnitus. (12784976)
2003
32
Characterization of cis-elements mediating the stimulation of glucose-6-phosphate transporter promoter activity by glucocorticoids. (14597389)
2003
33
Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. (12204887)
2002
34
The IGF/IGFBP system in CNS malignancy. (11477136)
2001
35
Enhanced expression of caspase-3 in hypertrophic scars and keloid: induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. (10744070)
2000
36
Cloning and characterization of two bistructural S-layer-RTX proteins from Campylobacter rectus. (10198015)
1999
37
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. (10611322)
1999
38
Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis]. (9759156)
1998
39
Epidural electrical stimulation of the motor cortex in patients with facial neuralgia. (9350402)
1997
40
Steroid receptor coactivator-1 is a histone acetyltransferase. (9296499)
1997
41
Hepatic fascioliasis: case report and review. (8762643)
1996
42
Distinct heme active-site structure in lactoperoxidase revealed by resonance Raman spectroscopy. (8399138)
1993
43
Solid phase extraction and simultaneous high performance liquid chromatographic determination of antipyrine and its major metabolites in urine. (1286289)
1992
44
Concentrations of blood and urine ethanol, acetaldehyde, acetate and acetone during experimental hangover in volunteers. (1785958)
1991
45
Purification and characterization of uridine and thymidine phosphorylase from Lactobacillus casei. (2119230)
1990
46
Neuraminidase production by a Streptococcus sanguis strain associated with subacute bacterial endocarditis. (6874067)
1983
47
Buerger's disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases. (7067357)
1982
48
Chronic Suppurative Otitis Media. Modified Radical Operation. (19991399)
1938
49
50

Variations for Pityriasis Rosea

About this section

Expression for genes affiliated with Pityriasis Rosea

About this section
Search GEO for disease gene expression data for Pityriasis Rosea.

Pathways for genes affiliated with Pityriasis Rosea

About this section

Pathways related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show top 31)    (show all 32)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.0HLA-A, HLA-B, HLA-C
29.0HLA-A, HLA-B, HLA-C
39.0HLA-A, HLA-B, HLA-C
49.0HLA-A, HLA-B, HLA-C
59.0HLA-A, HLA-B, HLA-C
6
Show member pathways
9.0HLA-A, HLA-B, HLA-C
78.6HLA-DRB1, HLA-DRB4, HLA-DRB5
8
Show member pathways
8.5HLA-DRB1, HLA-DRB4, HLA-DRB5
9
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
10
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
11
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
12
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
13
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
14
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
15
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
168.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
178.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
188.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
198.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
208.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
21
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
22
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
236.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
246.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
256.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
26
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
27
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
286.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
29
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
30
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
31
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

GO Terms for genes affiliated with Pityriasis Rosea

About this section

Cellular components related to Pityriasis Rosea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:00426139.8HLA-DQB1, HLA-DRB4
2integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.3HLA-C, HLA-DQB1, HLA-DRB4
3cell surfaceGO:00099869.0HLA-A, HLA-B, HLA-C
4external side of plasma membraneGO:00098978.6HLA-DRB1, HLA-DRB4, HLA-DRB5
5trans-Golgi network membraneGO:00325888.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
6ER to Golgi transport vesicle membraneGO:00125077.9HLA-A, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

Biological processes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1protection from natural killer cell mediated cytotoxicityGO:004227010.0HLA-A, HLA-B
2positive regulation of T cell mediated cytotoxicityGO:000191610.0HLA-A, HLA-B
3peptide antigen assembly with MHC class II protein complexGO:00025039.8HLA-DRB1, HLA-DRB4
4negative regulation of T cell proliferationGO:00421309.7HLA-DRB4, HLA-DRB5
5humoral immune response mediated by circulating immunoglobulinGO:00024559.6HLA-DRB1, HLA-DRB4
6antigen processing and presentation of peptide antigen via MHC class IGO:00024749.4HLA-A, HLA-B, HLA-C
7regulation of interleukin-10 secretionGO:20011799.3HLA-DRB1, HLA-DRB4, HLA-DRB5
8T-helper 1 type immune responseGO:00420889.2HLA-DRB1, HLA-DRB4, HLA-DRB5
9viral processGO:00160329.0HLA-A, HLA-B, HLA-C
10immunoglobulin production involved in immunoglobulin mediated immune responseGO:00023818.8HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
11immune responseGO:00069558.6HLA-DRB1, HLA-DRB4, HLA-DRB5
12interferon-gamma-mediated signaling pathwayGO:00603338.5HLA-A, HLA-B, HLA-C, HLA-DRB4
13antigen processing and presentationGO:00198828.0HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB5

Molecular functions related to Pityriasis Rosea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426058.6HLA-A, HLA-B, HLA-DRB4

Sources for Pityriasis Rosea

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet